Heart failure (HF) is the terminal manifestation of various cardiovascular diseases. Recently,
accumulating evidence has demonstrated that gut microbiota are involved in the …

Introduction and objectives Meteorin-like protein (Metrnl) is a cytokine involved in the
attenuation of inflammation. In patients with heart failure, high levels of this biomarker are …

Cardiorenal syndrome type 3 (CRS 3) occurs when there is an acute kidney injury (AKI)
leading to the development of an acute cardiac injury. The immune system is involved in …

Omega-3 fatty acids are potential anti-inflammatory agents that may exert beneficial
outcomes in diseases characterised by increased inflammatory profile. The purpose of this …

Background Chagas disease, endemic in Latin America and spreading globally due to
emigration, has a significant health burden, particularly in relation to chagasic heart failure …

Abstract Background N7-methylguanosine (m7G) modification has been reported to regulate
RNA expression in multiple pathophysiological processes. However, little is known about its …

The study is devoted to investigating the profile of molecular markers of fibrosis in Wistar rats
exposed to different doses of doxorubicin. Forty male Wistar rats weighing 260±19 g were …

The high consumption of simple carbohydrates and saturated fat is associated with a
positive energy balance and fat accumulation. This scenario has been contributing to …

Cardiometabolic diseases are associated with low-grade inflammation early in life and
persists into old age. The long latency period presents opportunities for early detection …

The prevalence of heart failure (HF) continues to rise globally and is now at epidemic
proportions. At least 6.7 million Americans $20 years of age have HF, and this number will …